Search details
1.
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens.
Clin Infect Dis
; 72(8): 1342-1349, 2021 04 26.
Article
in English
| MEDLINE | ID: mdl-32161944
2.
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S20-S30, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645159
3.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645160
4.
Screening and Enrollment by Sex in Human Immunodeficiency Virus Clinical Trials in the United States.
Clin Infect Dis
; 71(5): 1300-1305, 2020 08 22.
Article
in English
| MEDLINE | ID: mdl-31563942
5.
The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
Ann Intern Med
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38684100
6.
Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.
Clin Infect Dis
; 68(2): 273-279, 2019 01 07.
Article
in English
| MEDLINE | ID: mdl-29868833
7.
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
N Engl J Med
; 375(18): 1726-1737, 2016 11 03.
Article
in English
| MEDLINE | ID: mdl-27806243
8.
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Am Heart J
; 212: 23-35, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30928825
9.
Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.
Am Heart J
; 212: 1-12, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30928823
10.
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Clin Infect Dis
; 67(3): 420-429, 2018 07 18.
Article
in English
| MEDLINE | ID: mdl-29538636
11.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
N Engl J Med
; 373(9): 795-807, 2015 Aug 27.
Article
in English
| MEDLINE | ID: mdl-26192873
12.
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Ann Intern Med
; 167(6): 384-393, 2017 Sep 19.
Article
in English
| MEDLINE | ID: mdl-28828489
13.
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
J Infect Dis
; 215(2): 238-246, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27811319
14.
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.
Ann Intern Med
; 163(12): 908-17, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26595748
15.
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.
Clin Infect Dis
; 61(7): 1179-88, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26060295
16.
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
Clin Infect Dis
; 60(10): 1552-8, 2015 May 15.
Article
in English
| MEDLINE | ID: mdl-25694653
17.
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.
Antimicrob Agents Chemother
; 59(4): 2094-101, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25624326
18.
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.
HIV Clin Trials
; 16(4): 147-56, 2015 08.
Article
in English
| MEDLINE | ID: mdl-26212575
19.
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.
Clin Infect Dis
; 56(7): 1044-51, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23300238
20.
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
NEJM Evid
; 2(3)2023 Mar.
Article
in English
| MEDLINE | ID: mdl-37213438